Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding lapse notice was added, informing users that information may not be up to date and that the NIH Clinical Center is open, and the page now shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedA glossary toggle was added to the page. Capitalization updates were made to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag was updated to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 (Revision: v3.3.4 added; v3.3.3 removed). No substantive content or functionality of the study page is affected.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing site locations (California, Kentucky, Maryland, Massachusetts, Ohio, Virginia) to the study page and reorganized location information. The HHS Vulnerability Disclosure link was removed and revision labels updated (v3.3.3 from v3.3.2).SummaryDifference0.6%

- Check85 days agoChange DetectedRevision line updated to v3.3.2, replacing the previous v3.3.1. This update does not alter study details, eligibility, or outcome data.SummaryDifference0.0%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.